Skip to content

The efficacy of adjuvant morphine to bupivacaine in thoracic paravertebral block for postoperative analgesia in video-assisted thoracoscopic surgery: A randomized, Double-blind controlled trial

The efficacy of adjuvant morphine to bupivacaine in thoracic paravertebral block for postoperative analgesia in video-assisted thoracoscopic surgery: A randomized, Double-blind controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260227006
Enrollment
70
Registered
2026-02-27
Start date
2026-02-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postthoracotomy pain is regarded as one of the fiercest pain during perioperative periods(2). Although the minimally invasive thoracoscopic technique has been widely practiced and markedly reduced pain degree compared with traditional open-chest surgery, moderate to severe pain still takes place and proves to be associated with impaired lung secretion clearance, delayed mobilization, and delayed ventilatory recovery after surgery, prolonged hospital stays. Postthoracotomy pain

Interventions

0.5% Bupivacaine 20 ml with morphine 3 mg,0.5% Bupivacaine 20 ml with normal saline 0.3 ml
Experimental Drug,Placebo Comparator Drug
Additional morphine to paravertebral,Additional normal saline

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Age 18-80 years 2 ASA physical status I-III 3 Undergoing elective video-assisted thoracoscopic surgery 4 Able and willing to provide informed consent 5 Patients appreciate to participate in this study with sign

Exclusion criteria

Exclusion criteria: 1 Contraindication of paravertebral block 2 Known allergy to any drug used on the study protocol 3 Chronic use of opioids 4 Previous thoracic surgery 5 BMI > 35 kg/m2 6Preexisting neuropathy 7 Severe DM (HbA1C>7%) 8 Severe cardiopulmonary disease 9 Severe thoracic kyphosis

Design outcomes

Primary

MeasureTime frame
median time to first analgesic request Single time Minutes

Secondary

MeasureTime frame
the total cumulative morphine consumption via Patient-Controlled Analgesia (PCA) at 6, 12, and 24 hours postoperativel Single tine Miligram

Countries

Thailand

Contacts

Public ContactSateeya Dadsanthia

Faculty of ramathibodi hospital

sateeya3101@gmail.com0917745968

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026